StockWatch
·
Healthcare Research- Analytics & Technology
Business Update24 Mar 2026, 05:11 pm

Vanta Bioscience Ltd Closes Trading Window for Insider Trading

AI Summary

Vanta Bioscience Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and all other concerned persons. This closure is in accordance with the Company’s Code of Conduct for Prohibition of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from Wednesday, April 01, 2026 till the expiry of 48 hours after the declaration of the Audited Financial Results of the Company for the half year and year ended March 31, 2026. The date of the board meeting for consideration and declaration of the Audited Financial Results will be intimated in due course.

Key Highlights

  • Vanta Bioscience Ltd closes trading window for insider trading
  • Closure in accordance with the Company’s Code of Conduct for Prohibition of Insider Trading and SEBI regulations
  • Closure effective from Wednesday, April 01, 2026
  • Trading window to reopen after 48 hours of Audited Financial Results declaration
  • Board meeting date for Audited Financial Results declaration to be intimated later